Nutanix price target raised to $72 from $68 at RBC Capital

RBC Capital analyst Matthew Hedberg raised the firm’s price target on Nutanix to $72 from $68 and keeps an Outperform rating on the shares. The company reported another strong quarter highlighted by outperformance in ACV billings, revenue and free cash flow, which included achieving GAAP profitability for the first time, all despite an uneven environment, the analyst tells investors in a research note.